MedTrace Logo

Mycophenolate Mofetil (MMF): A Long-Term Data Evaluation

NCT00203671 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 651

Last updated 2010-07-13

No results posted yet for this study

Summary

The purposes of this study are:

* To review past clinical use of mycophenolate mofetil (MMF) in kidney transplant patients;
* To discover why doses were modified and how those modifications affected the survival and health of the transplanted kidney; and
* To determine whether, therefore, the side effects of MMF that result in dose alterations are related to outcome.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Alan H Wilkinson, MD · University of California, Los Angeles

  • Ralph Barbeito, Ph.D. · Novartis Pharmaceuticals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Completion
2007-05-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00203671 on ClinicalTrials.gov